<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0014">
 <label>14.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Höner Zu Siederdissen</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Maasoumy</surname>
    <given-names>B</given-names>
   </name>, 
   <name name-style="western">
    <surname>Deterding</surname>
    <given-names>K</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting</article-title>. 
  <source>Liver Int</source>
  <year>2015</year>; 
  <volume>35</volume>:
  <fpage>1845</fpage>–
  <lpage>1852</lpage>.
  <pub-id pub-id-type="pmid">25556625</pub-id>
 </mixed-citation>
</ref>
